CryoLife (United States)
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CryoLife (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
52%
Total
Publications
130
Total Open
Publications
68
Total
Citations
2.7K
Open Access
Percentage
52%
Total
Publications
130
Total Open
Publications
68
Total
Citations
2.7K
Breakdown
Publisher Open
38%
Both
11%
Other Platform Open
4%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 6%
4
Hybrid 67%
42
No Guarantees 27%
17
Other Platform Open
Domain 74%
14
Institution 16%
3
Preprint 11%
2
Public 11%
2
Other Internet 11%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 14 |
Europe PMC | Domain | 8 |
Semantic Scholar | Public | 2 |
arXiv | Preprint | 2 |
University of Exeter - Open Research Exeter | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
Red Federada de Repositorios Institucionales de Publicaciones CientÃficas - LA Referencia | Other Internet | 1 |
OSF Preprints - ECSarXiv | Preprint | 1 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 1 |
California Digital Library - eScholarship | Other Internet | 1 |